| SC 13G/A | 2021-05-10 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 18,685,695 | 10.9% | EDGAR |
| SC 13G/A | 2021-02-16 | Point72 Asset Management, L.P. | Verastem, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Ridgeback Capital Investments L.P. | Verastem, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | CITADEL ADVISORS LLC | Verastem, Inc. | - | 0.1% | EDGAR |
| SC 13G/A | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | Verastem, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 10,144,039 | 6.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Ikarian Capital, LLC | Verastem, Inc. | 2,254,591 | 1.3% | EDGAR |
| SC 13G/A | 2021-02-12 | Vivo Opportunity, LLC | Verastem, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-11 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 5,942,821 | 3.5% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | Verastem, Inc. | 9,012,578 | 5.3% | EDGAR |
| SC 13G/A | 2021-02-05 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Verastem, Inc. | 8,615,384 | 4.8% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Verastem, Inc. | 13,491,716 | 7.9% | EDGAR |
| SC 13G/A | 2020-07-10 | RA CAPITAL MANAGEMENT, L.P. | Verastem, Inc. | 9,129,251 | 5.6% | EDGAR |
| SC 13G | 2020-03-11 | Vivo Opportunity, LLC | Verastem, Inc. | 6,654,632 | 4.8% | EDGAR |
| SC 13G | 2020-03-09 | Ikarian Capital, LLC | Verastem, Inc. | 5,051,875 | 6.8% | EDGAR |
| SC 13G/A | 2020-03-06 | Ridgeback Capital Investments L.P. | Verastem, Inc. | 10,068,243 | 8.3% | EDGAR |
| SC 13G | 2020-03-05 | RA CAPITAL MANAGEMENT, L.P. | Verastem, Inc. | 18,604,651 | 13.5% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 3,130,642 | 4.2% | EDGAR |
| SC 13G/A | 2020-02-14 | CITADEL ADVISORS LLC | Verastem, Inc. | - | 7.7% | EDGAR |
| SC 13G/A | 2020-02-14 | D. E. SHAW & CO, L.P. | Verastem, Inc. | 3,830,302 | 4.9% | EDGAR |